The global Veterinary Point-of-Care Testing Devices Market is expanding with the growing demand for rapid and convenient diagnostic solutions in animal healthcare. Increasing pet ownership, rising awareness of animal health, and the need for faster detection of infectious and chronic diseases are supporting market development. Advances in portable analyzers, blood testing systems, and rapid diagnostic technologies are further improving testing efficiency across veterinary clinics and hospitals.

The global Veterinary Point-of-Care Testing Devices Market is projected to reach US$ 4.74 billion by 2034 from US$ 2.9 billion in 2025, registering a CAGR of 6.34% during 2026–2034. Veterinary point-of-care testing (POCT) devices enable veterinarians to obtain diagnostic information rapidly at clinics, hospitals, farms, and other animal-care settings. Increasing companion animal ownership, rising expenditure on veterinary healthcare, growing prevalence of animal diseases, and demand for faster diagnosis are supporting the expansion of this market.

What is driving the market?

The increasing demand for rapid and accessible veterinary diagnostics is a major factor driving the Veterinary Point-of-Care Testing Devices Market. Point-of-care systems allow veterinarians to obtain diagnostic results closer to the time and location of patient care, supporting faster clinical assessment and treatment decisions.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPRE00011109

The growing companion animal population is an important market driver. Dogs and cats are increasingly receiving preventive healthcare, routine screening, and specialized veterinary treatment. As pet owners become more attentive to animal health, demand for diagnostic testing is expanding beyond basic clinical examinations.

The increasing prevalence of infectious and chronic diseases in animals is also contributing to market growth. Conditions affecting the gastrointestinal, renal, hepatic, cardiovascular, endocrine, and immune systems may require laboratory testing to support diagnosis and treatment monitoring.

Veterinary clinics are also seeking more efficient workflows. In-house testing can reduce dependence on external laboratories for selected diagnostic procedures and may shorten turnaround times. This is particularly valuable in emergency and critical-care situations where rapid information can influence treatment decisions.

Growth in livestock and production-animal healthcare further broadens market opportunities. Rapid testing can support disease surveillance, herd health management, and veterinary decision-making in agricultural settings.

Which region leads?

North America represents a significant region in the Veterinary Point-of-Care Testing Devices Market, supported by developed veterinary healthcare infrastructure, high companion animal ownership, and substantial spending on animal healthcare. The region has an established network of veterinary clinics, hospitals, diagnostic laboratories, and specialized animal-care facilities.

Europe also represents an important market due to increasing attention to animal welfare, established veterinary services, and growing demand for preventive and diagnostic care. Veterinary professionals are increasingly using diagnostic technologies to support early disease detection and treatment management.

Asia Pacific is expected to provide substantial growth opportunities as pet ownership increases and veterinary healthcare infrastructure develops. Rising disposable incomes, growing awareness of animal health, and expansion of veterinary clinics are supporting demand for diagnostic technologies.

The livestock sector also creates opportunities across emerging economies, where rapid testing can support disease control and herd management.

Which segment leads?

Clinical chemistry and hematology testing represent important application areas in the Veterinary Point-of-Care Testing Devices Market because they provide essential information about an animal's overall physiological and health status. These tests can support the assessment of organ function, blood parameters, metabolic conditions, and other clinical indicators.

Immunodiagnostic testing is another important area, particularly for identifying infectious diseases and specific biological markers. Rapid immunoassays can provide veterinarians with timely information during routine examinations and emergency cases.

Point-of-care testing is also increasingly relevant to infectious disease management. Rapid identification of pathogens or disease-associated markers can support timely isolation, treatment, and disease-control decisions.

Testing for companion animals represents a substantial area of demand as veterinary clinics increasingly adopt advanced diagnostic capabilities. At the same time, production-animal applications provide opportunities for portable and rapid testing systems that can be used in farms and field environments.

Portable analyzers and compact diagnostic platforms are particularly valuable where access to centralized laboratories is limited. Ease of operation, test turnaround time, sample requirements, and result reliability remain important purchasing considerations.

Which companies are prominent?

The report profiles IDEXX Laboratories, Abaxis, BIONOTE Co., LTD, Diagon, LifeAssays AB, AniPOC Ltd., Bio-X Diagnostics S.A., Biomed Diagnostics, Inc., Zoetis, and Heska Corporation as industry participants while analyzing competitive strategies and innovation developments.

The competitive landscape includes companies developing veterinary analyzers, rapid diagnostic tests, immunoassays, hematology systems, clinical chemistry platforms, and other point-of-care technologies. Companies compete through diagnostic accuracy, test menu breadth, turnaround time, instrument usability, portability, and distribution networks.

Manufacturers are expanding the range of tests available through compact platforms, allowing veterinary practices to perform multiple diagnostic procedures in-house. Integration of analyzers with veterinary practice-management and laboratory-information systems is also becoming increasingly relevant.

Companies are also focusing on improving access to diagnostic technologies in smaller clinics and emerging markets through portable systems, simplified workflows, and broader distribution partnerships.

What is changing in 2026?

The Veterinary Point-of-Care Testing Devices Market is increasingly shifting toward portable, connected, automated, and multi-parameter diagnostic systems. Veterinary professionals are seeking technologies that can provide rapid results without requiring extensive laboratory infrastructure.

Portable analyzers are gaining importance because they can be used in veterinary clinics, emergency settings, farms, shelters, and field environments. Compact designs can make diagnostic testing more accessible where centralized laboratory services are unavailable or impractical.

Digital connectivity is another important trend. Connected diagnostic systems can transfer test results to electronic veterinary records and support more efficient documentation and clinical workflows.

Automation is also influencing product development. Automated sample handling, analysis, and result interpretation can reduce manual steps and improve operational efficiency in busy veterinary practices.

The growing use of multiplex testing is further expanding the capabilities of point-of-care platforms. Systems that can evaluate multiple parameters from a single sample can provide veterinarians with broader diagnostic information during a single visit.

What are the major investment opportunities?

Investment opportunities are expanding across portable analyzers, rapid infectious-disease testing, multiplex diagnostics, connected veterinary devices, and point-of-care technologies for livestock and companion animals. Companies that provide accurate and easy-to-use diagnostic solutions can address the growing demand for faster veterinary decision-making.

Companion animal healthcare offers an important opportunity as pet owners increasingly seek preventive care and advanced diagnostics. Veterinary clinics are expanding their diagnostic capabilities to provide more comprehensive services within the practice.

Livestock diagnostics represent another area of opportunity. Rapid point-of-care testing can support disease surveillance and herd-health programs, particularly when early identification is important for limiting disease spread and economic losses.

Connected veterinary diagnostics can also create new opportunities. Integration with practice-management systems and digital health records can improve access to diagnostic information and support more coordinated patient management.

Emerging markets provide additional growth potential as veterinary infrastructure expands. Manufacturers can strengthen market penetration through affordable platforms, localized distribution, training, and after-sales technical support.

Going forward, market participants should consider diagnostic accuracy, turnaround time, test-menu breadth, portability, automation, connectivity, sample requirements, ease of use, cost efficiency, and regulatory compliance when evaluating opportunities in the Veterinary Point-of-Care Testing Devices Market.

Related Reports @

Veterinary Ophthalmology Equipment Market Growth, Trends & Forecast by 2034

Veterinary Healthcare Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish